The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multi-institutional feasibility study of S-1/oxaliplatin (SOX) plus bevacizumab in patients with advanced/metastatic colorectal cancer: HiSCO-02 prospective phase II study.
 
Manabu Kurayoshi
No Relationships to Disclose
 
Katsunori Shinozaki
No Relationships to Disclose
 
Takao Hinoi
No Relationships to Disclose
 
Tsuyoshi Kobayashi
No Relationships to Disclose
 
Manabu Shimomura
No Relationships to Disclose
 
Masanori Yoshimitsu
No Relationships to Disclose
 
Kazuhiro Toyota
No Relationships to Disclose
 
Masahiro Nakahara
No Relationships to Disclose
 
Yasuyo Ishizaki
No Relationships to Disclose
 
Yuzo Hirata
No Relationships to Disclose
 
Shinya Kodama
No Relationships to Disclose
 
Yosuke Shimizu
No Relationships to Disclose
 
Koji Kawaguchi
No Relationships to Disclose
 
Masakazu Tokunaga
No Relationships to Disclose
 
Daisuke Sumitani
No Relationships to Disclose
 
Hideki Ohdan
No Relationships to Disclose